Compounds > lopinavir
Page last updated: 2024-08-26

lopinavir and Jaundice

lopinavir has been researched along with Jaundice in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Duburcq, T; Lassailly, G; Levy, C; Mathurin, P; Parmentier, E; Poissy, J1
Deng, K; Lv, XH; Yang, JL1

Other Studies

3 other study(ies) available for lopinavir and Jaundice

ArticleYear
Caution With the Use of Lopinavir/Ritonavir in Severely Ill Patients for the Treatment of SARS-CoV-2: A Report of Severe Jaundice.
    The American journal of gastroenterology, 2020, Volume: 115, Issue:10

    Topics: Aged; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Female; Humans; Intensive Care Units; Jaundice; Lopinavir; Male; Middle Aged; Pandemics; Pneumonia, Viral; Prospective Studies; Retrospective Studies; Ritonavir; SARS-CoV-2; Severity of Illness Index; Standard of Care

2020
Lopinavir-Ritonavir and Liver Involvement in Patients With COVID-19.
    The American journal of gastroenterology, 2021, 05-01, Volume: 116, Issue:5

    Topics: Antiviral Agents; COVID-19 Drug Treatment; Humans; Jaundice; Liver; Lopinavir; Ritonavir; SARS-CoV-2

2021
Atazanavir: new indication. First-line treatment: fewer gastrointestinal disorders but more cases of jaundice and a risk of torsades de pointes.
    Prescrire international, 2009, Volume: 18, Issue:101

    Topics: Anti-HIV Agents; Anti-Retroviral Agents; Atazanavir Sulfate; Drug Approval; Drug Therapy, Combination; Europe; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Jaundice; Lopinavir; Oligopeptides; Pyridines; Pyrimidinones; Randomized Controlled Trials as Topic; Ritonavir; Torsades de Pointes; Viral Load

2009